Multicenter, double-blind, placebo-controlled, flexible dose (100–400 mg) 10 week evaluation of the safety and efficacy of Lamictal (lamotrigine) in the treatment of a major depressive episode in patients with bipolar disorder (summary report of trial SCAA2010, updated 2005, 5 pp) - Glaxo-SmithKline Corporation
(accessed 1 March 2013)